Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

ARVO news: First-in-human clinical study of RetinoStat in wet AMD

May 5, 2015

New efficacy data presented for the antibody-drug conjugate ASN-004

May 5, 2015

AstraZeneca discloses novel PI3Kalpha/delta inhibitior

May 5, 2015

GSK-2330672 as a treatment for pruritus associated with primary biliary cirrhosis

May 4, 2015

Pharmacokinetic assessments of RG-101 in healthy volunteers and HCV patients

May 4, 2015

Hamni Pharmaceutical divulges preclinical data of HM-95573

May 4, 2015

Researchers report development of second-generation BTK inhibitors

May 4, 2015

First preclinical results presented for a novel HER2-targeted ADC

May 4, 2015

Anti-GDF-15 MAb restores CACS-associated phenotypic and metabolic changes

May 4, 2015

Anti-inflammatory effects of amylin(28-33) described for the first time

April 30, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...